Evaluation of the U.S. Marshals Service’s Pharmaceutical Drug Costs and Procurement Process
- NARA ID
- evaluation-us-marshals-services-pharmaceutical-drug-costs-and-procurement-process
- Source
- oig-doj
- Collection
- DOJ OIG — U.S. Marshals Service
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2022-12-21
- Slug
- doj-oig-evaluation-us-marshals-services-pharmaceutical-drug-costs-and-procurement-process
- Indexed
- 2026-04-27 05:02:06
More from DOJ OIG — U.S. Marshals Service
- Audit of the United States Marshals Service’s Blanket Purchase Agreement for Executive, Administrative, and Professional Support Services Awarded to Mayvin, Incorporated
- Audit of the United States Marshals Service's Procurement Activities
- Audit of the United States Marshals Service's Administration of Joint Law Enforcement Operation Funds
- Audit of the Department of Justice's Handling of Sex Offenders in the Federal Witness Security Program
- Audit of the United States Marshals Service's Property and Asset Control Enterprise Solution Pursuant to the Federal Information Security Modernization Act of 2014 Fiscal Year 2017
- Audit of the Financial Management of the United States Marshals Service's Office in the Superior Court of the District of Columbia
Browse all 47 documents in DOJ OIG — U.S. Marshals Service →
About the DOJ OIG — U.S. Marshals Service collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning United States Marshals Service.